-
公开(公告)号:US11339159B2
公开(公告)日:2022-05-24
申请号:US16926933
申请日:2020-07-13
Applicant: Pfizer Inc.
Inventor: Omar Ahmad , Andrew Fensome , Erik Alphie LaChapelle , Ethan Lawrence Fisher , Rayomand J. Unwalla , Jun Xiao , Lei Zhang
IPC: C07D471/04 , A61K31/437
Abstract: The present invention relates to imidazo-pyridinyl compounds, or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject.
-
公开(公告)号:US11976064B2
公开(公告)日:2024-05-07
申请号:US17738074
申请日:2022-05-06
Applicant: Pfizer Inc.
Inventor: Omar Ahmad , Andrew Fensome , Erik Alphie LaChapelle , Ethan Lawrence Fisher , Rayomand J. Unwalla , Jun Xiao , Lei Zhang
IPC: A61K31/4745 , A61K31/437 , C07D471/04
CPC classification number: C07D471/04 , A61K31/437
Abstract: The present invention relates to imidazo-pyridinyl compounds, or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject.
-
公开(公告)号:US20220274986A1
公开(公告)日:2022-09-01
申请号:US17738074
申请日:2022-05-06
Applicant: Pfizer Inc.
Inventor: Omar Ahmad , Andrew Fensome , Erik Alphie LaChapelle , Ethan Lawrence Fisher , Rayomand J. Unwalla , Jun Xiao , Lei Zhang
IPC: C07D471/04 , A61K31/437
Abstract: The present invention relates to imidazo-pyridinyl compounds, or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject.
-
公开(公告)号:US20210017172A1
公开(公告)日:2021-01-21
申请号:US16926933
申请日:2020-07-13
Applicant: Pfizer Inc.
Inventor: Omar Ahmad , Andrew Fensome , Erik Alphie LaChapelle , Ethan Lawrence Fisher , Rayomand J. Unwalla , Jun Xiao , Lei Zhang
IPC: C07D471/04 , A61K31/437
Abstract: The present invention relates to imidazo-pyridinyl compounds, or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject.
-
-
-